Accessibility Menu
 
Tanke Biosciences logo

Tanke Biosciences

(OTC) TNBI

Current Price$0.04
Market Cap$880,100
Since IPO (2011)-96%
5 Year-40%
1 Year+19%
1 Month-17%

Tanke Biosciences Financials at a Glance

Market Cap

$880,100

Revenue (TTM)

$8.43K

Net Income (TTM)

$274.36K

EPS (TTM)

$-0.01

P/E Ratio

-3.73

Dividend

$0.00

Beta (Volatility)

-0.02 (Low)

Price

$0.04

Volume

10

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.02 - $0.06

TNBI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tanke Biosciences

Industry

Commercial Services and Supplies

CEO

Vincent W. Renz, Jr., MBA

Headquarters

Las Vegas, 510627, CN

TNBI Financials

Key Financial Metrics (TTM)

Gross Margin

81%

Operating Margin

-30%

Net Income Margin

-33%

Return on Equity

0%

Return on Capital

64%

Return on Assets

-4%

Earnings Yield

-26.81%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$880.10K

Shares Outstanding

21.84M

Volume

10

Avg. Volume

1.58K

Financials (TTM)

Gross Profit

$6.87K

Operating Income

$257.87K

EBITDA

$256.30K

Operating Cash Flow

$36.99K

Capital Expenditure

$3.00

Free Cash Flow

$36.99K

Cash & ST Invst.

$6.01K

Total Debt

$140.00K

Tanke Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$880.10K

N/A

Market Cap/Employee

$6.77K

N/A

Employees

130

N/A

Net Income

$49.22K

+14.6%

EBITDA

$46.57K

-7.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$133.99K

+4.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$140.00K

+0.0%

Return on Assets

-3.68%

N/A

Return on Invested Capital

64.22%

N/A

Free Cash Flow

$870.00

-109.2%

Operating Cash Flow

$869.00

-109.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
QYBXQian Yuan Baixing, Inc.
$0.01+0.00%
CRVHChilco River Holdings, Inc.
$0.01-20.77%
AIKOAlternative Investment Corporation
$1.13+0.00%
IVFZFMapath Capital Corp.
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%

Questions About TNBI

What is the current price of Tanke Biosciences?

Tanke Biosciences is trading at $0.04 per share.

What is the 52-week range for Tanke Biosciences?

Over the past 52 weeks, Tanke Biosciences has traded between $0.02 and $0.06.

How much debt does Tanke Biosciences have?

As of the most recent reporting period, Tanke Biosciences reported total debt of $140,000.

How much cash does Tanke Biosciences have on hand?

Tanke Biosciences reported $6,013 in cash and cash equivalents in its most recent financial results.

What is Tanke Biosciences’s dividend yield?

Tanke Biosciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.